What Has Been The Evolution of the Ocular Implants Market in Recent Years?
The ocular implants market has seen considerable growth due to a variety of factors.
• The market for ocular implants has experienced significant expansion in the past few years. The market size is projected to increase from $14.76 billion in 2024 to $16.36 billion in 2025, representing a compound annual growth rate (CAGR) of 10.8%.
The substantial growth during the historic period can be ascribed to factors such as ocular trauma, vision correction, diabetic retinopathy, eye diseases, and regulatory approvals.
What Is the Forecasted Market Size and Growth Rate for The Ocular Implants Market?
The ocular implants market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the ocular implants market size is anticipated to experience quick expansion. The market is projected to reach $25.32 billion by 2029, with a compound annual growth rate of 11.5%.
Key factors driving this growth during the forecast period include an increase in the aging population, the growing incidence of myopia, advances in glaucoma management, minimally invasive surgery techniques, and an emphasis on patient safety. During this period, the major trends to look out for are predicted to be technological advancements, innovations in ophthalmology, shifts towards digital healthcare, regenerative medicine developments, and the application of artificial intelligence (AI).
What Factors Are Driving Growth In The Ocular Implants Market?
The anticipated increase in the global elderly population is predicted to fuel the expansion of the ocular implants market. The term "geriatric population" pertains to a specific demographic of individuals who are generally 65 years old or above. Ocular implants offer remedies for prevalent age-associated eye conditions such as cataracts, glaucoma, and presbyopia witnessed in geriatrics, consequently enhancing vision, lessening dependence on vision correction eyewear, and boosting quality of life for seniors. For example, data from the World Health Organization in October 2022, an international public health body based in Switzerland, forecasts that the worldwide population of people aged 60 years and over is expected to surge from 1 billion in 2020 to 1.4 billion by 2022. Furthermore, by 2030, one in every six people globally will be over 60 years old. As a result, the surge in the elderly population worldwide will stimulate the ocular implants market's expansion.
What Are The Main Segments Of The Global Ocular Implants Market?
The ocular implants market covered in this report is segmented –
1) By Product: Intraocular Lens, Corneal Implants, Orbital Implants, Glaucoma Implants, Other Products
2) By Application: Glaucoma Surgery, Diabetic Retinopathy, Age-Related Macular Degeneration
3) By End-User: Specialty Eye Institutes, Hospitals, Clinics
Subsegments:
1) By Intraocular Lens (IOL): Monofocal IOL, Multifocal IOL, Toric IOL, Accommodative IOL
2) By Corneal Implants: Synthetic Corneal Implants, Donor Corneal Implants, Intracorneal Ring Segments (ICRS)
3) By Orbital Implants: Porous Orbital Implants, Non-Porous Orbital Implants
4) By Glaucoma Implants: Aqueous Shunts Or Valves, Micro-Invasive Glaucoma Surgery (MIGS) Devices
5) By Other Products: Scleral Buckles, Ocular Prosthesis, Retinal Implants
Pre-Book The Ocular Implants Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Ocular Implants Market?
Leading businesses in the ocular implants market are directing their efforts towards the creation of innovative solutions, such as axitinib intravitreal implants, to expand the range of treatment options available for eye conditions like retinal vein occlusion and diabetic macular edema. Axitinib intravitreal implants are miniature devices that release drugs, which are placed straight into the vitreous cavity of the eye for controlled, sustained axitinib delivery, a tyrosine kinase inhibitor. An illustrative example is Ocular Therapeutix, Inc., a pharmaceutical firm from the US, which has initiated a crucial clinical trial for its own axitinib intravitreal implant variant, OTX-TKI, targeting the treatment of wet age-related macular degeneration (wet AMD). This trial aims to measure the safety and effectiveness of the implant in preserving visual sharpness in comparison to the customary aflibercept treatment. The study is set up as a multi-center, randomized experiment involving approximately 300 patients, and hopes to determine the potential of OTX-TKI to offer a sustained drug release, which could lessen the need for frequent injections for treatment of the condition.
Who Are the Key Players in the Ocular Implants Market?
Major companies operating in the ocular implants market include:
• Alcon Inc.
• Bausch & Lomb Inc.
• Carl Zeiss AG
• STAAR Surgical Company
• Johnson and Johnson Services Inc.
• Morcher GmbH
• Aurolab Ltd.
• Cornea Biosciences
• KERAMED INC.
• Price Vision Group
• Gulden Ophthalmics Co. Inc.
• AJL Ophthalmic SA
• Hoya Corp.
• Rayner Intraocular Lenses Limited
• Lenstec Inc.
• SIFI S.p.A
• Ophtec BV
• HumanOptics AG
• Medicontur Medical Engineering Ltd.
• Hanita Lenses
• Omni Lens Pvt. Ltd.
• EyeKon Medical Inc.
• FCI Ophthalmics Inc.
• Santen Pharmaceutical Co. Ltd.
• Ocular Therapeutix Inc.
• AcuFocus Inc.
• Glaukos Corporation
• Ivantis Inc.
What Is The Most Dominant Region In The Ocular Implants Market?
North America was the largest region in the ocular implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ocular implants market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
